Literature DB >> 2587947

A prospective study of infectious morbidity and antibiotic consumption among children in different forms of municipal day-care.

C Petersson1, A Häkansson.   

Abstract

During the 9-month period September 1986-May 1987, reasons for absence and antibiotic consumption were investigated among children cared for in day-care center(s) (DCC) and Swedish town. family day-care (FDC) within a limited geographical area of a medium-sized Swedish town. All 352 children in 11 DCC in this area and 199 children in FDC were included in this prospective study, which intended to elucidate the infectious morbidity. The investigation period comprised 55,760 and 26,019 expected days' attendance for the DCC and FDC children, respectively. A higher absence attributable to infection was evident at all ages in DCC children than in those in FDC. This difference tended to diminish with age. No difference in antibiotic consumption was evident between the 2 categories, and the diagnostic pattern was almost identical. In the DCC, overall absence figures, and absence due to infection, were considerably lower than in earlier comparable studies. Appreciable differences in absence due to infection and antibiotic consumption were also found between different "departments" in the DCC; both low and high-absence groups could be identified. There was an indication of differences between the groups both socially and in the environment at the DCC.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2587947     DOI: 10.3109/00365548909167451

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  2 in total

1.  Drug consumption during the first 18 months of life of infants from smoking and non-smoking families.

Authors:  A Håkansson; C Petersson
Journal:  Br J Gen Pract       Date:  1992-09       Impact factor: 5.386

2.  Higher risk for acute childhood lymphoblastic leukaemia in Swedish population centres 1973-94. Swedish Child Leukaemia Group.

Authors:  U Hjalmars; G Gustafsson
Journal:  Br J Cancer       Date:  1999-01       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.